Cold Spring Harbor Laboratory announced a collaboration with GSK to develop a treatment for obesity and type 2 diabetes Read the full story

GSK has agreed to the sale of 28.2 million ordinary shares in Aspen Pharmacare Holdings Read the full story

GlaxoSmithKline and Sun Pharmaceutical have reached an agreement related to GSK’s Opiates business in Australia Read the full story

The International AIDS Vaccine Initiative has received a grant of US$350,000 from GSK to support implementation of the Human Vaccines Project, Read the full story

GSK has acquired GlycoVaxyn Read the full story

Dynavax Technologies has regained full rights to DV1179, an investigational bifunctional inhibitor of toll-like receptors (TLR) 7 and 9 Read the full story

Clovis Oncology have entered into a clinical trial collaboration with GlaxoSmithKline to evaluate a novel combination therapy targeting mutant epidermal growth factor receptor (EGFR) non-small cell lung cancer (NSCLC) Read the full story

Medidata announced the completion of a method development project conducted in partnership with GlaxoSmithKline to evaluate the impact of unifying mobile health (mHealth) devices Read the full story

GlaxoSmithKline and Johnson & Johnson will become pharma partnering for increasing production of an Ebola vaccine, with an aim to produce at least 1 million doses next year. Read the full story

GlaxoSmithKline will acquire a stake in the Japanese subsidiary of Aspen Pharmacare Holdings as part of an alliance to boost commercial operations in the Asian country. Read the full story